Therapeutic Equivalence of Single Oral Doses of Dolasetron Mesilate and Multiple Doses of Ondansetron for the Prevention of Emesis After Moderately Emetogenic Chemotherapy

Author: European Dolasetron Comparative Study Group   Fauser A.A.   Duclos B.   Chemaissani A.   Del Favero A.   Cognetti F.   Diaz-Rubio E.   Cortes-Funes H.   Conte P.F.   Dressler H.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.32, Iss.9, 1996-08, pp. : 1523-1529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content